{"status": "OK", "response": {"docs": [{"type_of_material": "News", "blog": [], "news_desk": "National Desk", "lead_paragraph": "A growing body of research is leading many medical experts to ask whether more is really better when it comes to health care. Some medical specialties and geographical areas are suffering from a glut of doctors and hospitals, these experts say. Supply seems to drive demand. More hospitals in an area mean many more days spent in hospitals with no discernible improvements in health. More medical specialists mean many more specialist visits and procedures.", "headline": {"main": "More May Not Mean Better In Health Care, Studies Find"}, "abstract": "Growing body of research leads many medical experts to question whether more is really better in terms of health care; experts say some medical specialties and geographical areas are suffering from glut of doctors and hospitals, and supply seems to drive demand; say more hospitals in area may mean many more days spent in hospitals with no discernible improvements in health; Dr John E Wennberg, leader of research team at Dartmouth Medical School, comments; charts (M)", "print_page": "1", "word_count": 1447, "_id": "4fd26a548eb7c8105d821ce8", "snippet": "A growing body of research is leading many medical experts to ask whether more is really better when it comes to health care.    Some medical specialties and geographical areas are suffering from a glut of doctors and hospitals, these experts say....", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2002/07/21/us/more-may-not-mean-better-in-health-care-studies-find.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "persons", "value": "WENNBERG, JOHN E"}, {"name": "organizations", "value": "DARTMOUTH COLLEGE"}, {"name": "subject", "value": "HEALTH INSURANCE"}, {"name": "subject", "value": "DOCTORS"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}, {"name": "subject", "value": "HOSPITALS"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Gina", "lastname": "KOLATA"}], "original": "By GINA KOLATA"}, "document_type": "article", "pub_date": "2002-07-21T00:00:00Z", "section_name": "Health; U.S."}, {"type_of_material": "News", "blog": [], "news_desk": "National Desk", "lead_paragraph": "Michael Krygowski curses his shortness of breath while coaching his 10- year-old son's baseball team. He dreads dying before his three children finish college. And the 40-cent tax rise that took effect July 1 brings his two packs of Marlboro Lights to $8.70 a day -- $269.70 this month. ''That's a pretty big car payment,'' Mr. Krygowski, 39, who lives in Hirscher, Ill., lamented during a call to a smokers' ''quit line'' today. ''I am just sick of smoking. I'm tired of the way I feel.", "headline": {"main": "Facing New Costs, Some Smokers Say 'Enough'"}, "abstract": "Sixteen states and New York City have raised taxes on cigarettes this year, and some smokers are thinking more seriously about quitting in face of higher costs; studies suggest that price increase of 10 percent reduces smoking about 4 percent; sales of nicotine patches and gum are reportedly increasing along with higher cigarette prices; in Springfield, Ill, smokers have flooded hot line run by American Lung Assn since state raised cigarette tax; hot line counselors and smokers comment; chart of cigarette tax increases and projected tax revenue in 16 states; photo (M)", "print_page": "14", "word_count": 1118, "_id": "4fd21eef8eb7c8105d7a1ad2", "snippet": "Michael Krygowski curses his shortness of breath while coaching his 10- year-old son's baseball team. He dreads dying before his three children finish college. And the 40-cent tax rise that took effect July 1 brings his two packs of Marlboro Lights...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2002/07/17/us/facing-new-costs-some-smokers-say-enough.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "glocations", "value": "NEW YORK CITY"}, {"name": "glocations", "value": "ILLINOIS"}, {"name": "glocations", "value": "SPRINGFIELD (ILL)"}, {"name": "organizations", "value": "AMERICAN LUNG ASSN"}, {"name": "subject", "value": "SALES"}, {"name": "subject", "value": "STATES (US)"}, {"name": "subject", "value": "TAXATION"}, {"name": "subject", "value": "PRICES (FARES, FEES AND RATES)"}, {"name": "subject", "value": "NICOTINE"}, {"name": "subject", "value": "SMOKING AND TOBACCO"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Jodi", "lastname": "WILGOREN"}], "original": "By JODI WILGOREN"}, "document_type": "article", "pub_date": "2002-07-17T00:00:00Z", "section_name": "U.S."}, {"type_of_material": "News", "blog": [], "news_desk": "Science Desk", "lead_paragraph": "Menopause is not a disease, as doctors often point out, only an inevitability of middle age. But for most women, it does come with symptoms, as the body is weaned from its customary diet of estrogen. Some of these can be more than a little annoying: sudden spikes in temperature that make the face flush and the sweat flow; soaked sheets at 3 a.m.; vaginal dryness that causes incessant pain and itching. An estimated 20 million American women have been treating these problems and also trying to preserve the strength of their bones and hearts by taking daily doses of estrogen to replace what their ovaries no longer provide. But then came last week's announcement that hormone replacement therapy caused small but significant increases in breast cancer, heart attack, stroke and blood clots in a nationwide study of postmenopausal women. And now many women are wondering if they may want to try something else.", "headline": {"main": "Hormone Therapy: One Size, Clearly, No Longer Fits All"}, "abstract": "Article on issues estimated 20 million American women may have to consider following announcement that hormone replacement therapy has caused small but significant increases in breast cancer, heart attacks, strokes and blood clots in nationwide study of postmenopausal women; chart; photo (M)", "print_page": "1", "word_count": 1904, "_id": "4fd21ac48eb7c8105d799796", "snippet": "Menopause is not a disease, as doctors often point out, only an inevitability of middle age. But for most women, it does come with symptoms, as the body is weaned from its customary diet of estrogen. Some of these can be more than a little annoying:...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2002/07/16/science/hormone-therapy-one-size-clearly-no-longer-fits-all.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "subject", "value": "HEART"}, {"name": "subject", "value": "ESTROGEN"}, {"name": "subject", "value": "HORMONES"}, {"name": "subject", "value": "BREAST"}, {"name": "subject", "value": "STROKE"}, {"name": "subject", "value": "CANCER"}, {"name": "subject", "value": "MENOPAUSE"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Mary", "lastname": "DUENWALD"}], "original": "By MARY DUENWALD"}, "document_type": "article", "pub_date": "2002-07-16T00:00:00Z", "section_name": "Science; Health"}, {"type_of_material": "Op-Ed", "blog": [], "news_desk": "Editorial Desk", "lead_paragraph": "There are at least 6 million women in this country who are asking themselves, ''What happened?'' Over the last several years they have read books and magazine articles, listened to TV pundits and talked to doctors and friends -- all of whom assured them that taking hormone replacement therapy for the rest of their lives would keep them healthy. Then one bright summer day, their world shifted. Their little daily pill carried not the promise of health but the risk of disease. How could this be?", "headline": {"main": "Preventive Medicine, Properly Practiced"}, "abstract": "Dr Susan M Love Op-Ed article on new research calling safety of hormone replacement therapy into question; says underlying issue is tendency in health care, driven by wishful thinking and marketing, to jump ahead of medical evidence; offers examples of other therapies whose dangers only became apparent after they were widely used; says foundation of prevention still should be lifestyle changes, and drugs should be secondary (M)", "print_page": "17", "word_count": 785, "_id": "4fd21ac48eb7c8105d79979f", "snippet": "There are at least 6 million women in this country who are asking themselves, ''What happened?'' Over the last several years they have read books and magazine articles, listened to TV pundits and talked to doctors and friends -- all of whom assured...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2002/07/16/opinion/preventive-medicine-properly-practiced.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "subject", "value": "ESTROGEN"}, {"name": "subject", "value": "HORMONES"}, {"name": "subject", "value": "LIFE STYLES"}, {"name": "subject", "value": "MARKETING AND MERCHANDISING"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "CANCER"}, {"name": "subject", "value": "PROGESTIN"}, {"name": "subject", "value": "MENOPAUSE"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}, {"name": "subject", "value": "RESEARCH"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1}], "original": "By Susan M. Love"}, "document_type": "article", "pub_date": "2002-07-16T00:00:00Z", "section_name": "Health; Opinion"}, {"type_of_material": "News", "blog": [], "news_desk": "National Desk", "lead_paragraph": "The Senate began a boisterous election-year debate on prescription drugs today as Democrats and Republicans unveiled competing proposals to add drug benefits to Medicare and to rein in pharmaceutical costs. Senator Judd Gregg, Republican of New Hampshire, objected tonight when Democrats asked for unanimous consent to take up a bill expanding access to low-cost generic versions of brand-name drugs. The objection forced Democrats to make a formal motion to proceed, ensuring that no swift action would occur.", "headline": {"main": "Senate Begins Debate on Rival Medicare Prescription Plans"}, "abstract": "Senate begins debate on prescription drugs as Democrats and Republicans unveil competing proposals to add drug benefits to Medicare and to rein in pharmaceutical costs; Democrats fail to get unanimous consent to take up bill expanding access to low-cost generic versions of brand-name drugs, thus ensuring that no swift action will occur on legislation approved in committee last week; photo (M)", "print_page": "12", "word_count": 882, "_id": "4fd27f578eb7c8105d849286", "snippet": "The Senate began a boisterous election-year debate on prescription drugs today as Democrats and Republicans unveiled competing proposals to add drug benefits to Medicare and to rein in pharmaceutical costs.    Senator Judd Gregg, Republican of New...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2002/07/16/us/senate-begins-debate-on-rival-medicare-prescription-plans.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "glocations", "value": "UNITED STATES"}, {"name": "subject", "value": "GENERIC AND BRAND NAME PRODUCTS"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "PRICES (FARES, FEES AND RATES)"}, {"name": "subject", "value": "AGED"}, {"name": "subject", "value": "MEDICARE"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}, {"name": "subject", "value": "LAW AND LEGISLATION"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Robert", "lastname": "PEAR"}], "original": "By ROBERT PEAR"}, "document_type": "article", "pub_date": "2002-07-16T00:00:00Z", "section_name": "Health; U.S."}, {"type_of_material": "News", "blog": [], "news_desk": "Business/Financial Desk", "lead_paragraph": "Some money managers are beginning to say that the pharmaceutical industry has suffered enough. At beaten-down prices, the stocks are likely to be good long-term investments, they say, whether or not the industry quickly benefits from a wave of mergers. Over the last year, investors have treated pharmaceutical stocks worse than the overall market. One drug stock, Bristol-Myers Squibb, has lost more than half its value in 2002.", "headline": {"main": "Market Place; New Prospects for the Battered Drug Stocks"}, "abstract": "Some money managers are saying that pharmaceutical stocks are likely to be good long-term investments whether or not industry quickly benefits from wave of mergers; drug companies have made numerous missteps: bets on wrong products, run-ins with regulators, and failures to quell talks in Washington and elsewhere that prices are susceptible to being reduced; news that Pfizer will acquire Pharmacia helps lift prices of few drug stocks; graph (Market Place column) (M)", "print_page": "1", "word_count": 967, "_id": "4fd27f578eb7c8105d849285", "snippet": "Some money managers are beginning to say that the pharmaceutical industry has suffered enough. At beaten-down prices, the stocks are likely to be good long-term investments, they say, whether or not the industry quickly benefits from a wave of...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2002/07/16/business/market-place-new-prospects-for-the-battered-drug-stocks.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "organizations", "value": "PHARMACIA CORP"}, {"name": "organizations", "value": "PFIZER INC"}, {"name": "subject", "value": "MERGERS, ACQUISITIONS AND DIVESTITURES"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "PRICES (FARES, FEES AND RATES)"}, {"name": "subject", "value": "INDUSTRY PROFILES"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}, {"name": "subject", "value": "REGULATION AND DEREGULATION OF INDUSTRY"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Reed", "lastname": "ABELSON"}], "original": "By REED ABELSON"}, "document_type": "article", "pub_date": "2002-07-16T00:00:00Z", "section_name": "Business"}, {"type_of_material": "News", "blog": [], "news_desk": "National Desk", "lead_paragraph": "Last week, when a large federal study on hormone replacement therapy came to an abrupt halt, Cheryl Kipfer's husband handed her a news report on the stunning findings. The drugs, the report said, had risks, including invasive breast cancer, which, although slight, were not counterbalanced by benefits. Ms. Kipfer said her husband, Gary, told her she was crazy. ''Why,'' she said he asked her, ''are you taking those pills?''", "headline": {"main": "Many Taking Hormone Pills Now Face a Difficult Choice"}, "abstract": "Many menopausal women involved in hormone replacement therapy using drugs estrogen and progestin face difficult choices following federal report that drugs involve risks, including invasive breast cancer, which although slight are not counterbalanced by benefits; must contend with recurrence of severe symptoms of menopause that drugs have squelched, such as hot flashes and thinning of bones from osteoporosis; photos (M)", "print_page": "1", "word_count": 2006, "_id": "4fd21cf78eb7c8105d79d5fa", "snippet": "Last week, when a large federal study on hormone replacement therapy came to an abrupt halt, Cheryl Kipfer's husband handed her a news report on the stunning findings. The drugs, the report said, had risks, including invasive breast cancer, which,...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2002/07/15/us/many-taking-hormone-pills-now-face-a-difficult-choice.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "subject", "value": "ESTROGEN"}, {"name": "subject", "value": "HORMONES"}, {"name": "subject", "value": "BREAST"}, {"name": "subject", "value": "CANCER"}, {"name": "subject", "value": "WOMEN"}, {"name": "subject", "value": "PROGESTIN"}, {"name": "subject", "value": "MENOPAUSE"}, {"name": "subject", "value": "OSTEOPOROSIS"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Gina", "lastname": "KOLATA"}], "original": "By GINA KOLATA"}, "document_type": "article", "pub_date": "2002-07-15T00:00:00Z", "section_name": "Front Page; Health; U.S."}], "meta": {"hits": 7, "offset": 0, "time": 43}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}